Buy or sell Arsenal Medical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Arsenal Medical Stock

Arsenal Medical develops novel products that improve local therapy for injuries and diseases.

About Arsenal Medical Stock

Arsenal Medical uses conventional biomaterials in unconventional ways to develop novel products that improve local therapy for injury and disease. The company is advancing multiple preclinical programs based on both its two proprietary technology platforms: its therapeutic foam and AxioCore, a novel, high-throughput nanofiber technology. Arsenal Medical is supported by venture funding, as well as grants from the Department of Defense, National Institute of Standards and Technology’s Technology Innovation Program (NIST-TIP) and the Bill & Melinda Gates Foundation. Its investors include Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

Funding History

April 2009$8.2M
January 2010$2.0M
January 2010$2.0M
March 2010$1.0M
May 2010$10.0M
August 2010$3.0M
September 2011$3.0M
October 2012$3.0M
August 2013$4.0M
June 2015$16.0M

Management

President and CEO

R. Scott Rader

Founder and Chairman

Carmichael Roberts

President and Chief Executive Officer

James J. Barry

Co-Founder

Robert Langer

Director of Materials Science and Engineering

Upma Sharma

Vice President, Research and Development

Toby Freyman

EVP & COO

James J. Barry

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Arsenal Medical or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo